Holen Sie sich die Stockscreener-App
14.04
3.16%
0.43
Handel nachbörslich:
14.47
0.43
+3.06%
Schlusskurs vom Vortag:
$13.61
Offen:
$13.52
24-Stunden-Volumen:
1.95M
Relative Volume:
0.97
Marktkapitalisierung:
$1.70B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-7.3508
EPS:
-1.91
Netto-Cashflow:
$-33.45M
1W Leistung:
-1.16%
1M Leistung:
+5.41%
6M Leistung:
-29.66%
1J Leistung:
-74.26%
1-Tages-Spanne:
$13.41
$14.44
1-Wochen-Bereich:
$13.17
$15.31
52-Wochen-Spanne:
$12.95
$57.78
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
14.04 | 1.70B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
State Street Corp Has $39.53 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Goldman Sachs Maintains 10x Genomics Inc(TXG) Sell Recommendation - MSN
10X Genomics' SWOT analysis: genomics firm navigates challenges, eyes recovery - Investing.com
Insider Sellers Might Regret Selling 10x Genomics Shares at a Lower Price Than Current Market Value - Simply Wall St
Barclays PLC Has $13.61 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10X Genomics' SWOT analysis: genomics firm's stock faces instrument demand headwinds - Investing.com
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting - The Eastern Progress Online
XTX Topco Ltd Purchases 31,844 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Reports Third Quarter 2024 Financial Results - The Eastern Progress Online
46,029 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Weiss Asset Management LP - MarketBeat
Quantinno Capital Management LP Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Charles Schwab Investment Management Inc. Has $14.71 Million Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics (FRA:1KJ) Current Ratio : 4.90 (As of Sep. 2024) - GuruFocus.com
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - The Eastern Progress Online
Point72 Asset Management L.P. Invests $27.78 Million in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Benjamin Edwards Inc. Buys 57,948 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Brokerages Set 10x Genomics, Inc. (NASDAQ:TXG) PT at $29.19 - MarketBeat
10x Genomics Inc (TXG) Stock Price Down 3.81% on Dec 5 - GuruFocus.com
10x Genomics (FRA:1KJ) EV-to-EBIT : -9.57 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (STU:1KJ) Shares Outstanding (EOP) : 121.0 Mil (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) Interest Coverage : 0 (At Loss) (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) Shareholder Yield % : 0.42% (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) EV-to-FCF : 68.14 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (STU:1KJ) Price-to-Operating-Cash-Flow : 50.18 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) 3-Year Revenue Growth Rate : 21.40% (As of Sep. 2024) - GuruFocus.com
10x Genomics (MEX:TXG) Shares Outstanding (EOP) : 121 Mil (As of Sep. 2024) - GuruFocus.com
Cinctive Capital Management LP Takes $3.67 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Inc (TXG) Shares Up 2.74% on Dec 2 - GuruFocus.com
Fmr LLC Has $301.85 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
TXG (10x Genomics) Enterprise Value : $1,561.6 Mil (As of Nov. 30, 2024) - GuruFocus.com
10x genomics chief scientific officer sells $79,485 in stock - Investing.com India
10x genomics chief scientific officer sells $79,485 in stock By Investing.com - Investing.com Australia
TXG (10x Genomics) 6-1 Month Momentum % : -31.43% (As of Nov. 26, 2024) - GuruFocus.com
TXG (10x Genomics) Effect of Exchange Rate Changes : $0.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
10x genomics CEO Serge Saxonov sells $91,612 in stock By Investing.com - Investing.com Australia
10x genomics CEO Serge Saxonov sells $91,612 in stock - Investing.com India
10x Genomics (LTS:0A88) Operating Cash Flow per Share : $0.33 (TTM As of Sep. 2024) - GuruFocus.com
TXG (10x Genomics) Net Intangibles Purchase And Sale : $-1.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Algert Global LLC Acquires 252,994 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics to Present at the Wolfe Research 2024 Healthcare Co - GuruFocus.com
Primecap Management Co. CA Buys 108,600 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Inc (TXG) Shares Up 4.21% on Nov 22 - GuruFocus.com
CIBC Asset Management Inc Has $360,000 Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Brown Capital Management LLC - MarketBeat
10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay Workflows - MSN
10 Best Genomics Stocks To Buy Right Now - Insider Monkey
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | See Remarks |
Nov 22 '24 |
Sale |
13.69 |
5,807 |
79,485 |
339,897 |
1.16%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):